Imagine being armed with precautionary measures to fight a disease – like being vaccinated before the flu season arrives.

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.

Mass General Brigham’s HPV-DeepSeek test enables much earlier cancer detection through a blood sample, creating a new ...

The researchers highlighted that by catching cancers early, patients may experience higher treatment success and require a ...

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

Head and neck cancer, a type of cancer that not only affects your muscles and nerves in the head and neck, but also salivary ...

When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of ...

While it's primarily known for its potential to cause cervical cancer, exposure to high-risk HPV can also lead to other cancers in both sexes, according to a statement released by the researchers.

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

Earlier this month, Bicara Therapeutics announced that the U.S. FDA granted Breakthrough Therapy Designation to its experimental immunotherapy combination, ficerafusp alfa with pembrolizumab, for the ...

DeepSeek, a blood test that detects HPV-linked head and neck cancers up to 10 years early with 99% accuracy. The breakthrough ...

The first vaccines, approved in 2006, protects against four strains, HPV-6, HPV-11, HPV-16 and HPV-18. Another, approved in 2009, protects against two high-risk strains, HPV-16 and HPV-18. The third, ...